Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
about
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) studyA PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus.A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseSix-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retestingThe BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.Human papillomavirus testing and genotyping in cervical screening.What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review.Understanding HPV tests and their appropriate applications.Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice.Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.Effect of glacial acetic acid pre-treatment of cervical liquid-based cytology specimens on the molecular detection of human papillomavirus.
P2860
Q30651813-1082DB0D-B1EB-46D1-97DA-C4A029411CC8Q34459447-840C3C5E-C884-4E50-87FB-1E13DC375976Q34789131-9F6D5C23-6486-452A-8490-EA2D9E9AB9FCQ35342179-6F9D7DA4-8127-4FEC-B3D2-F6C96433E33EQ36194955-5628EE6A-F892-453F-8168-FE6B5702D355Q36794559-60C39892-6147-4171-85BD-E7F5119C7C95Q36839838-4F02EA52-F10E-4231-82F0-F75A47321949Q37218627-94EC80BB-A1C1-4A38-AF30-43574060F1F8Q37909359-BE7C95C9-2842-4C91-81F7-4ED4813FBD8DQ37927189-E01AEFA9-C85F-4333-B48E-5B11D0FDAEF2Q38133612-440F6FBD-BBA3-4E61-89DF-6B1032B59F4EQ41124641-57A17714-C33C-44D1-A4CC-1F9C0E7A5A10Q47216037-76606581-24A0-49EC-8B84-10B4FCF08F44Q47233989-0F36BA61-F92B-40B0-9F70-50FAFB7B5DBD
P2860
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human papillomavirus testing i ...... ure 2 tests: systematic review
@ast
Human papillomavirus testing i ...... ure 2 tests: systematic review
@en
Human papillomavirus testing i ...... ure 2 tests: systematic review
@nl
type
label
Human papillomavirus testing i ...... ure 2 tests: systematic review
@ast
Human papillomavirus testing i ...... ure 2 tests: systematic review
@en
Human papillomavirus testing i ...... ure 2 tests: systematic review
@nl
prefLabel
Human papillomavirus testing i ...... ure 2 tests: systematic review
@ast
Human papillomavirus testing i ...... ure 2 tests: systematic review
@en
Human papillomavirus testing i ...... ure 2 tests: systematic review
@nl
P2860
P50
P921
P356
P1433
P1476
Human papillomavirus testing i ...... ure 2 tests: systematic review
@en
P2093
Matejka Rebolj
Sisse Helle Njor
P2860
P356
10.1136/BMJ.D2757
P407
P5008
P577
2011-05-23T00:00:00Z